Superior Genomics

Superior Genomics is an early-stage mental-health diagnostics company in Norway, Michigan, developing a blood test that distinguishes bipolar disorder from major depressive disorder. The test reads gene-expression bioprofiles detectable in a blood sample, discovered by company physician David Van Holla, and is positioned as the first objective blood-based mental health diagnostic. The company works with Paradise Genomics on the underlying genomic research.

An objective, blood-based gene-expression test for a diagnosis — bipolar disorder versus major depressive disorder — that is otherwise made entirely by subjective clinical assessment, where misclassification leads to the wrong drug class.